Opportunity
DIBBS #SPE2DP-26-T-4867
DLA Solicitation for Gabapentin Capsules, 100 mg, 100 Count Bottles
Posted
September 03, 2026
Respond By
September 08, 2026
Identifier
SPE2DP-26-T-4867
NAICS
424210
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharm FSA is soliciting quotations for Gabapentin Capsules, 100 mg, 100 count bottles. - Government Buyer: - Defense Logistics Agency (DLA) - Sub-agency: DLA Troop Support Medical Supply Chain Pharm FSA - OEMs and Vendors: - Marlex Pharmaceuticals Inc (NDC10135-0644-01) - Cipla USA Inc (NDC69097-0813-07) - Sciegen Pharmaceuticals Inc (NDC50228-0179-01) - Products Requested: - Gabapentin Capsules, 100 mg, 100 count bottles - NSN: 6505-01-387-1892 - Quantity: 5 bottles - Part numbers: NDC10135-0644-01, NDC69097-0813-07, NDC50228-0179-01 - Unique Requirements: - Delivery required within 5 days, FOB destination - Packaging and marking must comply with DLA medical standards and FDA regulations - Compliance with domestic sourcing laws, including the Berry Amendment and Buy American Act - Fast award process, no technical attachments provided
Description
GABAPENTIN CAPSULES (QTY: 5, NSN: 6505-01-387-1892, Purchase Request: 7016153280) Approved Sources: - CAGE: 1TAP7, Part No: NDC10135-0644-01, Company: MARLEX PHARMACEUTICALS INC - CAGE: 7WV84, Part No: NDC69097-0813-07, Company: CIPLA USA INC - CAGE: 8NLP1, Part No: NDC50228-0179-01, Company: SCIEGEN PHARMACEUTICALS INC